Notenboom Sylvia, Miller David S, Kuik Leon H, Smits Paul, Russel Frans G M, Masereeuw Rosalinde
Department of Pharmacology and Toxicology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, The Netherlands.
J Pharmacol Exp Ther. 2005 Nov;315(2):912-20. doi: 10.1124/jpet.105.089094. Epub 2005 Aug 5.
We previously showed that the function of renal multidrug resistance protein (Mrp) 2 (Abcc2) is reduced by endothelin (ET)-1 signaling through an ET(B) receptor, nitric-oxide synthase (NOS), cGMP, and protein kinase C and that this pathway was activated by several nephrotoxicants (Masereeuw et al., 2000; Terlouw et al., 2001; Notenboom et al., 2002, 2004). Here, we determined the long-term effects on Mrp2-mediated transport (luminal fluorescein methotrexate accumulation) of short-term (30 min) exposure to ET-1 and the aminoglycoside antibiotic, gentamicin. Our data show that over the 3 h following exposure, proximal tubules recovered fully from the initial decrease in Mrp2-mediated transport and that transport activity was not changed 9 h later. However, 24 h after exposure, luminal accumulation of an Mrp2 substrate had increased by 50%. Increased transport at 24 h was accompanied by an increased transporter protein content of the luminal plasma membrane as measured by immunostaining. Blocking ET-1 signaling at the ET(B) receptor or downstream at NOS or guanylyl cyclase abolished both stimulation of transport and increased transporter expression. Thus, regardless of whether signaling was initiated by a short exposure to ET-1 or to a nephrotoxicant, the time course of Mrp2 response to ET(B) signaling was the same and was multiphasic. Finally, when tubules were exposed to gentamicin for 30 min and removed to gentamicin-free medium for 24 h, they were less sensitive to acute gentamicin toxicity than paired controls not initially exposed to the drug. Thus, short-term exposure to ET-1 or gentamicin resulted in long-term protection against a second insult.
我们先前表明,内皮素(ET)-1通过ET(B)受体、一氧化氮合酶(NOS)、环鸟苷酸(cGMP)和蛋白激酶C发出信号,可降低肾多药耐药蛋白(Mrp)2(Abcc2)的功能,并且该途径被几种肾毒物激活(Masereeuw等人,2000年;Terlouw等人,2001年;Notenboom等人,2002年、2004年)。在此,我们确定了短期(30分钟)暴露于ET-1和氨基糖苷类抗生素庆大霉素对Mrp2介导的转运(管腔荧光素甲氨蝶呤蓄积)的长期影响。我们的数据表明,在暴露后的3小时内,近端小管从Mrp2介导的转运最初的下降中完全恢复,并且9小时后转运活性没有变化。然而,暴露后24小时,Mrp2底物的管腔蓄积增加了50%。24小时时转运增加伴随着通过免疫染色测量的管腔质膜转运蛋白含量增加。在ET(B)受体处或NOS或鸟苷酸环化酶下游阻断ET-1信号传导消除了转运刺激和转运蛋白表达增加。因此,无论信号是由短期暴露于ET-1还是肾毒物引发,Mrp2对ET(B)信号的反应时间进程是相同的且是多相的。最后,当小管暴露于庆大霉素30分钟并转移至不含庆大霉素的培养基中24小时时,它们对急性庆大霉素毒性的敏感性低于未最初暴露于该药物的配对对照。因此,短期暴露于ET-1或庆大霉素可导致对第二次损伤的长期保护。